Leffall, one of five surgeons to serve as president of two ACSs, the American Cancer Society and American College of Surgeons

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

We have known a giant—physically, mentally, fraternally, socially, professionally, ethically, spiritually. Now he is gone, but will be long remembered and loved.

Growing up as the son of educators in the segregated South, LaSalle Leffall was taught that education and character were key, and he learned that lesson well. He pursued excellence successfully in so many arenas, and his character was never questioned. This pursuit of excellence led him to become a physician, a surgeon, an oncologist, and a consistent, tenacious leader.

Being first became commonplace for him: the first African American president of the American Cancer Society (1994-1995), the first African American member of the Southern Surgical Association, the first African American president of the American College of Surgeons (2009-2010), one of five surgeons to serve as president of the two ACSs—and more, are among his many accomplishments.

A master orator with the memory of an elephant, LaSalle would hold his audience spellbound as he told stories, used extensive quotations, and made emphatic points, all without notes or prompters. Driven always by principle—never blustery, always emphatic—he would successfully sway opinion in his ongoing effort to right longstanding wrongs and to enhance understanding. His knowledge and ability in surgery, oncology, and health policy was prolific. He was ever-responsive. His counsel was in wide demand, even to some presidents of our nation.

Dr. LaSalle Leffall in O.R, #3
LaSalle D. Leffall, Jr. as a young surgeon in the 1960s. – Photo courtesy of Howard University Archives

He was a devoted family man, and he and Ruthie were an ever present and enviable team, like salt and pepper.

LaSalle was a charismatic leader during a time of sea change in our nation. So often it seems to occur in our good land and accrues to our general benefit—the right man at the right time.

He had friends in all spheres of influence and activity, including some of the giants of jazz. They taught him the importance of the “grace note.” It is with a grace note that he has left us.

Thank you, my old and true friend.


The author is an adjunct professor of surgery at Emory University School of Medicine.

LaMar S. McGinnis
Adjunct professor of surgery, Emory University School of Medicine

YOU MAY BE INTERESTED IN

When our hematological malignancy testing pilot project began in Eldoret, Kenya, there seemed to be a mismatch in relation to progress in healthcare. The region, like much of sub-Saharan Africa, had been focusing on combatting infectious diseases such as HIV and malaria—which was much-needed—yet cancer care was under-resourced. 
Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 
In modern oncology, important insights from clinical trials often emerge years after initial publication. As new therapies extend survival and transition more patients into long-term remissions, clinicians and researchers are increasingly looking beyond initial response rates to understand durability, long-term safety, and even the possibility of a cure. 
LaMar S. McGinnis
Adjunct professor of surgery, Emory University School of Medicine

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login